Drug
Pseudoephedrine
Pseudoephedrine: highest development phase Approved, developed by Aurobindo, Perrigo, Sanofi. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Aurobindo, Perrigo, Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| NOVAFED | Approved | |
| PSEUDOEPHEDRINE HYDROCHLORIDE | Approved | |
| pseudoephedrine hydrochloride 30 mg tablets NCT01744106 | Phase 3 | Nasal Congestion Associated With the Common Cold |
Latest
No recent events.
Follow Pseudoephedrine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.